cancer treatment News
Latest articles and news about cancer treatment on AXL Media.
Latest Articles
- New Magnetic Microrobotic Control System From University of Essex Promises to Revolutionize Targeted Cancer Therapy Precision
Published: Apr 29, 2026
Section: Health Technology
Engineers at the University of Essex have developed the Tuneable Magnetic End Effector, a sophisticated tool designed to guide medical microrobots through the body with unprecedent...
- University of British Columbia scientists achieve million-fold leap in targeting elusive cancer proteins
Published: Apr 28, 2026
Section: Medical News
Researchers have developed a breakthrough method to target intrinsically disordered proteins that were previously considered undruggable due to their flexible, shifting structures....
- Washington University Researchers Uncover Dual Immune Pathways Powering mRNA Cancer Vaccine Efficacy
Published: Apr 18, 2026
Section: Medical News
A groundbreaking study from Washington University School of Medicine reveals that mRNA cancer vaccines utilize a secondary, unconventional immune pathway involving cDC2 dendritic c...
- University of Chicago Researchers Identify Eye Health Nutrient Zeaxanthin as Potent Booster for Cancer Immunotherapy
Published: Apr 10, 2026
Section: Research
Scientists have discovered that zeaxanthin, a common carotenoid found in leafy greens, significantly enhances the ability of T cells to attack tumors. The study indicates that this...
- Max Planck Institute Study Unlocks Why Current BET Inhibitors Falter in Clinical Cancer Trials
Published: Apr 9, 2026
Section: Health
A breakthrough study from the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE) has identified the functional differences between BRD2 and BRD4, two proteins previousl...
- Ruhr University Researchers Develop Ruthenium Agent to Kill Cancer in Oxygen-Depleted Tumors
Published: Apr 7, 2026
Section: Medical News
A research group at Ruhr University Bochum has achieved a breakthrough in photodynamic therapy (PDT) by developing a ruthenium-based agent that remains lethal in hypoxic, oxygen-de...
- Case Western Study Warns Popular Vitamin B3 Supplements May Shield Pancreatic Cancer Cells from Chemotherapy Effects
Published: Apr 2, 2026
Section: Medical News
Researchers at Case Western Reserve University have discovered that NAD+ boosting supplements, including NMN and NR, can inadvertently help pancreatic cancer cells resist medical t...
- University of Göttingen Researchers Use Machine Learning to Predict Side Effects in Multiple Myeloma Treatment, Enabling Safer Outpatient Stem Cell Mobilization
Published: Apr 1, 2026
Section: Health Technology
A collaborative study involving the University of Göttingen and University Medical Center Göttingen has utilized machine learning to analyze the treatment data of patients with mul...
- University of Michigan Engineers Develop Protein Nanoparticles to Deliver Gene Therapy Without the Risks of Viral Vectors
Published: Mar 31, 2026
Section: Research
Researchers at the University of Michigan have successfully used protein-based nanoparticles to genetically modify human liver, kidney, and immune cells. This "artificial virus" al...
- Liposomal Nanotechnology Breakthrough Enhances Precision and Therapeutic Efficacy of Light-Based Cancer Treatments
Published: Mar 28, 2026
Section: Health
Researchers at the University of Johannesburg have developed a liposomal delivery platform that significantly improves the targeting and stability of photodynamic therapy (PDT). By...
- University of Maryland Cancer Center Secures $3 Million Federal Grant to Advance Oncology Health Equity Research
Published: Mar 28, 2026
Section: Health
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has been awarded a $3 million National Cancer Institute grant to launch the ARCH K12 Program....
- NAFDAC Issues Urgent Public Alert Over Counterfeit Mabthera Cancer Drug Circulating in Northern Nigeria
Published: Mar 24, 2026
Section: Africa
The National Agency for Food and Drug Administration and Control (NAFDAC) has identified a falsified version of the cancer drug Mabthera (Rituximab) 500mg/50ml currently in circula...